Comparing the effects of decreasing prescription opioid shipments and the release of an abuse deterrent OxyContin formulation on opioid overdose fatalities in WV: an interrupted time series study
Abstract Introduction The 2010 release of an abuse deterrent formulation (ADF) of OxyContin, a brand name prescription opioid, has been cited as a major driver for the reduction in prescription drug misuse and the associated increasing illicit opioid use and overdose rates. However, studies of this...
Na minha lista:
| Principais autores: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2024-01-01
|
| Colecção: | Substance Abuse Treatment, Prevention, and Policy |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1186/s13011-023-00587-2 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
